Restricting Benefits for Single Moms May Harm Mental Health

This article originally appeared here.
Share this content:
Restricting Benefits for Single Moms May Harm Mental Health
Restricting Benefits for Single Moms May Harm Mental Health

WEDNESDAY, July 11, 2018 (HealthDay News) -- An adverse impact on mental health is seen with reducing the age at which Lone Parent Obligations (LPO) -- which require lone parents in the United Kingdom to seek work as a condition for receiving welfare benefits -- apply, according to a study published in the July issue of The Lancet Public Health.

Srinivasa Vittal Katikireddi, Ph.D., from the University of Glasgow in the United Kingdom, and colleagues assessed data from lone mothers newly exposed to LPO when the age cutoff was reduced from 7 to 5 years in 2012 (intervention group 1), from 10 to 7 years in 2010 (intervention group 2), and for lone mothers who remained unexposed or were continuously exposed (control groups 1 and 2).

The researchers found that, compared with the control groups, there was a decrease in the mental health of lone mothers in the intervention groups. Scores on the Mental Component Summary (MCS) of the 12-item Short-Form Health Survey decreased by 1.39 and by 2.29 in intervention group 1 versus control groups 1 and 2, respectively. MCS scores decreased by 2.45 and 1.28 for intervention group 2 versus controls groups 1 and 2, respectively. Scores on the MCS decreased by 2.13 and 2.21 when pooling the two intervention groups compared with control groups 1 and 2, respectively.

"Our results suggest that requiring lone parents with school-age children to seek work as a condition of receiving welfare benefits adversely affects their mental health," the authors write.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »